Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Return on Capital Employed (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Return on Capital Employed over the past 9 years, most recently at 11748.17% for Q4 2023.

  • For Q4 2023, Return on Capital Employed fell 1167881.0% year-over-year to 11748.17%; the TTM value through Dec 2023 reached 11748.17%, down 1167881.0%, while the annual FY2023 figure was 292.75%, 23920.0% down from the prior year.
  • Return on Capital Employed for Q4 2023 was 11748.17% at Corbus Pharmaceuticals Holdings, down from 540.96% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 56.7% in Q1 2022 and troughed at 11748.17% in Q4 2023.
  • A 5-year average of 753.29% and a median of 126.53% in 2021 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 24632bps in 2021 and later plummeted -1167881bps in 2023.
  • Year by year, Return on Capital Employed stood at 324.67% in 2019, then surged by 44bps to 182.84% in 2020, then skyrocketed by 68bps to 57.93% in 2021, then fell by -20bps to 69.36% in 2022, then tumbled by -16838bps to 11748.17% in 2023.
  • Business Quant data shows Return on Capital Employed for CRBP at 11748.17% in Q4 2023, 540.96% in Q3 2023, and 142.07% in Q2 2023.